This guideline describes the management of dyslipidemia in patients with chronic kidney disease, including both adult and pediatric patients.
This document is a Chinese-language summary of KDIGO clinical practice guideline recommendations on dyslipidemia in chronic kidney disease. It covers lipid evaluation and cholesterol-lowering treatment for adults and children, including patients on long-term dialysis or after kidney transplantation.
The recommendations address statin or statin/ezetimibe use by age and kidney function, triglyceride management through lifestyle changes, and situations where therapy should not be started. This manual is written in Chinese.
Yes, lipid profile evaluation is recommended for newly diagnosed adult CKD patients, including those on long-term dialysis or after kidney transplantation.
Yes, statin or statin/ezetimibe combination therapy is recommended for adults aged 50 or older with eGFR below 60 mL/min/1.73 m2 who are not on long-term dialysis or kidney transplant.
No, statin or statin/ezetimibe combination therapy is not recommended in dialysis-dependent adults with CKD.
Lifestyle improvement is suggested for adults with CKD and hypertriglyceridemia.